Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on May 23, 2006, covering events occurring on May 18, 2006. The filing reports on actions taken at the Company's 2006 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity plan amendments rather than financial performance data.
Material Changes
At the Annual Meeting on May 18, 2006, stockholders approved an amendment to the Amended and Restated 2000 Stock Option and Incentive Plan. This amendment increased the total number of shares of common stock available for issuance under the Plan by 2,000,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to disclose the entry into a material definitive agreement regarding the stock option plan.
Investor Verification Checklist
- Verify the total number of shares authorized under the amended 2000 Stock Option and Incentive Plan.
- Review Exhibit 99.1 for the full text of the Amended and Restated 2000 Stock Option and Incentive Plan.
- Confirm the impact of the 2,000,000 share increase on potential dilution for existing shareholders.